These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

324 related articles for article (PubMed ID: 30659355)

  • 1. Deep brain stimulation for monogenic Parkinson's disease: a systematic review.
    Kuusimäki T; Korpela J; Pekkonen E; Martikainen MH; Antonini A; Kaasinen V
    J Neurol; 2020 Apr; 267(4):883-897. PubMed ID: 30659355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Subthalamic Deep Brain Stimulation With Motor, Functional, and Pharmacologic Outcomes in Patients With Monogenic Parkinson Disease: A Systematic Review and Meta-analysis.
    Artusi CA; Dwivedi AK; Romagnolo A; Pal G; Kauffman M; Mata I; Patel D; Vizcarra JA; Duker A; Marsili L; Cheeran B; Woo D; Contarino MF; Verhagen L; Lopiano L; Espay AJ; Fasano A; Merola A
    JAMA Netw Open; 2019 Feb; 2(2):e187800. PubMed ID: 30707228
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Early cognitive decline after bilateral subthalamic deep brain stimulation in Parkinson's disease patients with GBA mutations.
    Mangone G; Bekadar S; Cormier-Dequaire F; Tahiri K; Welaratne A; Czernecki V; Pineau F; Karachi C; Castrioto A; Durif F; Tranchant C; Devos D; Thobois S; Meissner WG; Navarro MS; Cornu P; Lesage S; Brice A; Welter ML; Corvol JC;
    Parkinsonism Relat Disord; 2020 Jul; 76():56-62. PubMed ID: 32866938
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genetic background and outcome of Deep Brain Stimulation in Parkinson's disease.
    Rizzone MG; Martone T; Balestrino R; Lopiano L
    Parkinsonism Relat Disord; 2019 Jul; 64():8-19. PubMed ID: 30121162
    [TBL] [Abstract][Full Text] [Related]  

  • 5. GBA-Associated Parkinson's Disease: Progression in a Deep Brain Stimulation Cohort.
    Lythe V; Athauda D; Foley J; Mencacci NE; Jahanshahi M; Cipolotti L; Hyam J; Zrinzo L; Hariz M; Hardy J; Limousin P; Foltynie T
    J Parkinsons Dis; 2017; 7(4):635-644. PubMed ID: 28777757
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The LRRK2 G2019S mutation status does not affect the outcome of subthalamic stimulation in patients with Parkinson's disease.
    Greenbaum L; Israeli-Korn SD; Cohen OS; Elincx-Benizri S; Yahalom G; Kozlova E; Strauss H; Molshatzki N; Inzelberg R; Spiegelmann R; Israel Z; Hassin-Baer S
    Parkinsonism Relat Disord; 2013 Nov; 19(11):1053-6. PubMed ID: 23932063
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are LRRK2 p.G2019S or GBA1 variants associated with long-term outcomes of deep brain stimulation for Parkinson's disease?
    Anis S; Goldberg T; Shvueli E; Kozlov Y; Redlich Y; Lavi N; Lavie I; Sosero YL; Gan-Or Z; Ungar L; Zibly Z; Greenbaum L; Fay-Karmon T; Hassin-Baer S
    Parkinsonism Relat Disord; 2024 Jul; 124():106008. PubMed ID: 38242744
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are patients with GBA-Parkinson disease good candidates for deep brain stimulation? A longitudinal multicentric study on a large Italian cohort.
    Avenali M; Zangaglia R; Cuconato G; Palmieri I; Albanese A; Artusi CA; Bozzali M; Calandra-Buonaura G; Cavallieri F; Cilia R; Cocco A; Cogiamanian F; Colucci F; Cortelli P; Di Fonzo A; Eleopra R; Giannini G; Imarisio A; Imbalzano G; Ledda C; Lopiano L; Malaguti MC; Mameli F; Minardi R; Mitrotti P; Monfrini E; Spagnolo F; Tassorelli C; Valentino F; Valzania F; Pacchetti C; Valente EM;
    J Neurol Neurosurg Psychiatry; 2024 Mar; 95(4):309-315. PubMed ID: 37879897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson-related genetics in patients treated with deep brain stimulation.
    Johansen KK; Jørgensen JV; White LR; Farrer MJ; Aasly JO
    Acta Neurol Scand; 2011 Mar; 123(3):201-6. PubMed ID: 20545633
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Greater improvement in LRRK2 G2019S patients undergoing Subthalamic Nucleus Deep Brain Stimulation compared to non-mutation carriers.
    Sayad M; Zouambia M; Chaouch M; Ferrat F; Nebbal M; Bendini M; Lesage S; Brice A; Brahim Errahmani M; Asselah B
    BMC Neurosci; 2016 Feb; 17():6. PubMed ID: 26831335
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained response to deep brain stimulation in LRRK2 parkinsonism with the Y1699C mutation.
    Perju-Dumbrava LD; McDonald M; Kneebone AC; Long R; Thyagarajan D
    J Parkinsons Dis; 2012; 2(4):269-71. PubMed ID: 23938256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Motor and Non-motor Outcomes of Deep Brain Stimulation across the Genetic Panorama of Parkinson's Disease: A Multi-Scale Meta-Analysis.
    Asimakidou E; Xiromerisiou G; Sidiropoulos C
    Mov Disord Clin Pract; 2024 May; 11(5):465-477. PubMed ID: 38318989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Genetic Etiology of Parkinson's Disease Does Not Robustly Affect Subthalamic Physiology.
    Weill C; Gallant A; Baker Erdman H; Abu Snineh M; Linetsky E; Bergman H; Israel Z; Arkadir D
    Mov Disord; 2023 Mar; 38(3):484-489. PubMed ID: 36621944
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapies for Genetic Forms of Parkinson's Disease: Systematic Literature Review.
    Over L; Brüggemann N; Lohmann K
    J Neuromuscul Dis; 2021; 8(3):341-356. PubMed ID: 33459660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Subthalamic deep brain stimulation in Parkinson's disease with SNCA mutations: Based on the follow-up to 10 years.
    Youn J; Oyama G; Hattori N; Shimo Y; Kuusimäki T; Kaasinen V; Antonini A; Kim D; Lee JI; Cho KR; Cho JW
    Brain Behav; 2022 Feb; 12(2):e2503. PubMed ID: 35040589
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression and treatment of a series of patients with advanced LRRK2-associated Parkinson's disease.
    Fernández-Pajarín G; Sesar Á; Jiménez-Martín I; Ares B; Castro A
    Neurologia (Engl Ed); 2023 Jun; 38(5):350-356. PubMed ID: 35644844
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Embracing Monogenic Parkinson's Disease: The MJFF Global Genetic PD Cohort.
    Vollstedt EJ; Schaake S; Lohmann K; Padmanabhan S; Brice A; Lesage S; Tesson C; Vidailhet M; Wurster I; Hentati F; Mirelman A; Giladi N; Marder K; Waters C; Fahn S; Kasten M; Brüggemann N; Borsche M; Foroud T; Tolosa E; Garrido A; Annesi G; Gagliardi M; Bozi M; Stefanis L; Ferreira JJ; Correia Guedes L; Avenali M; Petrucci S; Clark L; Fedotova EY; Abramycheva NY; Alvarez V; Menéndez-González M; Jesús Maestre S; Gómez-Garre P; Mir P; Belin AC; Ran C; Lin CH; Kuo MC; Crosiers D; Wszolek ZK; Ross OA; Jankovic J; Nishioka K; Funayama M; Clarimon J; Williams-Gray CH; Camacho M; Cornejo-Olivas M; Torres-Ramirez L; Wu YR; Lee-Chen GJ; Morgadinho A; Pulkes T; Termsarasab P; Berg D; Kuhlenbäumer G; Kühn AA; Borngräber F; de Michele G; De Rosa A; Zimprich A; Puschmann A; Mellick GD; Dorszewska J; Carr J; Ferese R; Gambardella S; Chase B; Markopoulou K; Satake W; Toda T; Rossi M; Merello M; Lynch T; Olszewska DA; Lim SY; Ahmad-Annuar A; Tan AH; Al-Mubarak B; Hanagasi H; Koziorowski D; Ertan S; Genç G; de Carvalho Aguiar P; Barkhuizen M; Pimentel MMG; Saunders-Pullman R; van de Warrenburg B; Bressman S; Toft M; Appel-Cresswell S; Lang AE; Skorvanek M; Boon AJW; Krüger R; Sammler EM; Tumas V; Zhang BR; Garraux G; Chung SJ; Kim YJ; Winkelmann J; Sue CM; Tan EK; Damásio J; Klivényi P; Kostic VS; Arkadir D; Martikainen M; Borges V; Hertz JM; Brighina L; Spitz M; Suchowersky O; Riess O; Das P; Mollenhauer B; Gatto EM; Petersen MS; Hattori N; Wu RM; Illarioshkin SN; Valente EM; Aasly JO; Aasly A; Alcalay RN; Thaler A; Farrer MJ; Brockmann K; Corvol JC; Klein C;
    Mov Disord; 2023 Feb; 38(2):286-303. PubMed ID: 36692014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Analysis of the genetic variability in Parkinson's disease from Southern Spain.
    Bandrés-Ciga S; Mencacci NE; Durán R; Barrero FJ; Escamilla-Sevilla F; Morgan S; Hehir J; Vives F; Hardy J; Pittman AM
    Neurobiol Aging; 2016 Jan; 37():210.e1-210.e5. PubMed ID: 26518746
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cognitive and behavioral symptoms in Parkinson's disease patients with the G2019S and R1441G mutations of the LRRK2 gene.
    Somme JH; Molano Salazar A; Gonzalez A; Tijero B; Berganzo K; Lezcano E; Fernandez Martinez M; Zarranz JJ; Gómez-Esteban JC
    Parkinsonism Relat Disord; 2015 May; 21(5):494-9. PubMed ID: 25840672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resequencing analysis of five Mendelian genes and the top genes from genome-wide association studies in Parkinson's Disease.
    Benitez BA; Davis AA; Jin SC; Ibanez L; Ortega-Cubero S; Pastor P; Choi J; Cooper B; Perlmutter JS; Cruchaga C
    Mol Neurodegener; 2016 Apr; 11():29. PubMed ID: 27094865
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.